Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
Clinical trial NCT02788175 · COMPLETED
Trial details
- NCT number
- NCT02788175
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-28
- Primary completion
- 2019-03-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.